Renalytix Plc Stock OTC Markets
Stocks
RENXF
GB00BYWL4Y04
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0398 USD | +10.25% |
|
+10.25% | -48.61% |
| 07-06 | WINNERS & LOSERS: Knights profit up; GoldStone raises GBP3.5 million | AN |
| 06-30 | WINNERS & LOSERS: Defence Holdings jumps; ADM Energy delays results | AN |
| Market Cap | 13.34M 11.55M 10.76M 9.91M 18.68M 1.27B 18.91M 126M 49.63M 634M 50.08M 48.98M 2.1B | P/E 2024 |
-0.45x | P/E 2025 | -1.34x |
|---|---|---|---|---|---|
| Enterprise Value | 17.94M 15.53M 14.48M 13.32M 25.13M 1.71B 25.44M 170M 66.75M 853M 67.36M 65.88M 2.83B | EV / Sales 2024 |
11,059,330x | EV / Sales 2025 | 12,499,418x |
| Free-Float |
73.31% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +10.25% | ||
| 1 week | +10.25% | ||
| Current month | +10.25% | ||
| 1 month | +10.25% | ||
| 3 months | +72.29% | ||
| 6 months | -48.61% | ||
| Current year | -48.61% |
| 1 week | 0.04 |  | 0.04 |
| 1 month | 0.04 | | 0.04 |
| Current year | 0.02 | | 0.06 |
| 1 year | 0.02 | | 0.18 |
| 3 years | 0.02 | | 1.39 |
| 5 years | 0.02 | | 12.42 |
| 10 years | 0.02 | | 17.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
James McCullough
CEO | Chief Executive Officer | 58 | 15/03/2018 |
Joel Jung
DFI | Director of Finance/CFO | 68 | 28/05/2024 |
Howard Doran
PSD | President | 65 | 30/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Julian Baines
CHM | Chairman | 62 | 05/11/2024 |
James McCullough
BRD | Director/Board Member | 58 | 15/03/2018 |
| Chairman | 74 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +10.25% | +10.25% | - | - | 17.04M | |
| +0.57% | +2.92% | +27.38% | -37.12% | 16.4B | |
| -0.51% | +4.36% | +6.50% | +114.13% | 1.83B | |
| -0.48% | +4.95% | -27.44% | -79.07% | 1.2B | |
| -0.22% | -0.44% | -34.37% | +22.50% | 984M | |
| -0.98% | +4.12% | -45.91% | -52.09% | 668M | |
| -2.01% | +3.27% | -47.59% | -52.01% | 547M | |
| +0.16% | +11.32% | +74.26% | -45.39% | 521M | |
| -0.16% | +3.23% | -50.19% | -46.62% | 393M | |
| -0.40% | +2.63% | -12.93% | -28.06% | 372M | |
| Average | +0.62% | +3.78% | -12.25% | -22.64% | 2.55B | |
| Weighted average by Cap. | +0.26% | +2.95% | +15.35% | -25.64% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.29 1.98 1.85 1.7 3.21 217.7 3.25 21.7 8.52 108.88 8.6 8.41 360.95 | 3 2.6 2.42 2.23 4.2 285.32 4.25 28.44 11.16 142.7 11.27 11.02 473.07 |
| Net income | -33.46M -28.96M -27M -24.85M -46.87M -3.18B -47.45M -317M -125M -1.59B -126M -123M -5.28B | -20.4M -17.66M -16.47M -15.15M -28.58M -1.94B -28.93M -193M -75.92M -970M -76.61M -74.93M -3.22B |
| Net Debt | 3.86M 3.34M 3.11M 2.86M 5.4M 367M 5.47M 36.55M 14.35M 183M 14.48M 14.16M 608M | 4.6M 3.98M 3.71M 3.42M 6.44M 437M 6.52M 43.62M 17.12M 219M 17.28M 16.89M 725M |
Employees
46
| Date | Price | Change | Volume |
|---|
Annual profits - Rate of surprise
- Stock Market
- Stocks
- RENX Stock
- RENXF Stock
Select your edition
All financial news and data tailored to specific country editions
